RevolKa Announces the Closing of a $1.7M Series A Extension Funding to Accelerate Drug-Discovery Programs August 30, 2024
RevolKa Announces the Closing of a $1.7M Series A Extension Funding to Accelerate Drug-Discovery Programs August 30, 2024